Date Posted: April 30, 2026

This billing and coding article has been revised and published for notice under contract numbers: 02101 (AK), 02201 (ID), 02301(OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).

Effective Date: June 13, 2026

Summary of Changes:

Effective 01/01/2023: Under Excluded CPT/HCPCS Codes, removed asterisk from C9399, J3490, J3590 Risankizumab-rzaa (Skyrizi™) subcutaneous use

Effective 06/13/2026: Under Excluded CPT/HCPCS Codes, added J3490, J3590, C9399 Nemolizumab-ilto (Nemluvio)

Visit the Self-Administered Drugs (SADs) webpage to view the Self-Administered Drug Exclusion List.

To view the complete listing of billing and coding articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Billing and Coding Articles webpage.